Verisol collagen peptides approved by ANVISA for use in food supplements
ANVISA (the National Health Surveillance Agency in Brazil) approves Verisol collagen peptides from Gelita for use in food supplements for skin health.
Photo © Shutterstock.com/goodluz
ANVISA (the National Health Surveillance Agency in Brazil) approves Verisol from Gelita (Sergeant Bluff, IA) for use in food supplements for skin health.
“The evaluation process put our product to a high standard test, and we are pleased that the Agency recognized the safety and efficacy of Verisol,” said Gelita’s Stephan Hausmanns, PhD, vice president, health and nutrition, in a press release. “This success also demonstrates Gelita’s continuous leadership within the collagen market, emphasizing that not all collagen peptides have an equal efficacy. Verisol is so far the only collagen peptide to prove its bioactive benefits for skin health in the Brazilian market.”
Verisol’s collagen peptides are designed to provide the highest possible efficacy in human skin by stimulating fibroblast cells in the dermis, which substantially increases the renewal and repair of collagen, elastin, and proteoglycans. As a result, the epidermis is supported from within to support skin firmness. Six studies support the efficacy of Verisol. Their effect on skin elasticity, wrinkles, fine lines, cellulite, nails, and hair was researched and confirmed.
Rousselot to showcase new collagen peptide research and targeted solutions at Vitafoods Europe 2024
April 25th 2024The company will be highlighting new research that demonstrates the ability of its Peptan collagen peptide brand to support sleep quality, reduce gastrointestinal discomfort, and enhance skin health, including density, hydration, and elasticity.
Judge denies CRN’s motion for preliminary injunction but its lawsuit against NY state will proceed
April 23rd 2024The judge in CRN's lawsuit against NY state's law banning the sale of weight management and muscle building supplements to minors has denied its motion for a preliminary injunction, but determined that CRN has standing to sue on behalf of its members.
